Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ALXN1840
ALXN1840
AstraZeneca dumps $855M, near-approval rare disease drug after talks with regulators
Fierce Biotech
Thu, 04/27/23 - 10:34 am
AstraZeneca
clinical trials
ALXN1840
Wilson disease
Data backs AZ’s Wilson disease drug, but with a question mark
Pharmaforum
Fri, 06/24/22 - 10:26 am
AstraZeneca
Wilson disease
Alexion
ALXN1840
After Ultomiris stumble, Alexion delivers a rare disease win for AZ
Pharmaforum
Thu, 08/26/21 - 11:09 am
AstraZeneca
Alexion
ALXN1840
Wilson disease